Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.55 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.16.
Market Cap
9.55T
Revenue
4.66T
Profits
186.63B
PE Ratio
51.16
Profit Margin
4.00%
Dividend Yield
0.37%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | -0.66% | 900,544 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 643.56B | -1.09% | 3,359,940 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 456.69B | -1.70% | 1,120,177 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 372.64B | -1.35% | 3,126,960 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 354.34B | -1.56% | 953,184 | 450.53B |
| 6 | NVS | Novartis AG | 300.07B | -1.66% | 677,538 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 257.89B | -0.82% | 1,184,810 | 61.37B |
| 8 | AMGN | Amgen Inc. | 237.84B | -0.09% | 696,092 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 234.46B | 0.06% | 635,665 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 210.23B | -2.18% | 6,542,933 | 50.34B |
| 11 | ABT | Abbott Laboratories | 193.96B | -1.76% | 2,505,898 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 184.13B | 0.28% | 1,201,018 | 30.46B |
| 13 | PFE | Pfizer Inc. | 160.30B | -0.62% | 11,667,925 | 63.70B |
| 14 | DHR | Danaher Corporation | 152.46B | 0.71% | 863,476 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 139.26B | 0.39% | 239,308 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 137.31B | -0.52% | 1,623,445 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.57B | -0.22% | 589,073 | 11.03B |
| 18 | SYK | Stryker Corporation | 125.50B | -0.75% | 915,926 | 25.84B |
| 19 | CVS | CVS Health Corporation | 119.16B | -1.22% | 1,519,593 | 412.65B |
| 20 | MDT | Medtronic plc | 116.75B | -0.88% | 2,682,983 | 36.36B |
| 21 | SNY | Sanofi | 109.28B | -1.03% | 1,214,120 | 55.89B |
| 22 | MCK | McKesson Corporation | 103.70B | -0.80% | 192,509 | 410.98B |
| 23 | GSK | GSK plc | 103.45B | -2.12% | 1,202,165 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.78B | -0.76% | 327,020 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.97B | -0.37% | 171,520 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 81.12B | -0.29% | 253,567 | 15.53B |
| 27 | CI | The Cigna Group | 73.92B | -0.40% | 259,521 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 68.49B | -1.89% | 6,709,693 | 21.00B |
| 29 | ARGX | argenx SE | 66.11B | 1.14% | 138,752 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.69B | -1.37% | 279,477 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.20B | -0.77% | 805,332 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 56.15B | -6.02% | 13,409,627 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.81B | -1.15% | 266,626 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.39B | 0.12% | 1,271,431 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.65B | -0.31% | 471,058 | 22.48B |
| 36 | NTRA | Natera, Inc. | 49.05B | 0.53% | 234,066 | 2.71B |
| 37 | RVMD | Revolution Medicines, Inc. | 47.20B | 2.21% | 1,746,651 | - |
| 38 | HUM | Humana Inc. | 46.81B | -0.32% | 206,702 | 145.68B |
| 39 | VEEV | Veeva Systems Inc. | 46.54B | 16.98% | 3,036,800 | 3.46B |
| 40 | MDLN | Medline Inc. | 45.75B | 0.64% | 3,060,809 | 29.94B |
| 41 | HLN | Haleon plc | 44.69B | -0.93% | 7,220,221 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 44.59B | 1.97% | 1,262,113 | 7.37B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.94B | -0.55% | 1,110,991 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 43.29B | 0.56% | 413,077 | 16.98B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 42.90B | -1.61% | 74,123 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.53B | -0.47% | 63,062 | 6.13B |
| 47 | WAT | Waters Corporation | 41.73B | 2.56% | 267,976 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 35.66B | 0.34% | 770,576 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.16B | -0.12% | 287,132 | 10.86B |
| 50 | ILMN | Illumina, Inc. | 34.78B | 2.44% | 713,759 | 4.49B |
| 51 | RMD | ResMed Inc. | 34.20B | 0.60% | 508,190 | 5.65B |
| 52 | DXCM | DexCom, Inc. | 34.04B | 1.41% | 1,104,461 | 4.97B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 32.92B | -0.59% | 771,358 | 21.27B |
| 54 | BIIB | Biogen Inc. | 32.72B | 0.17% | 137,298 | 10.03B |
| 55 | CNC | Centene Corporation | 32.54B | 0.61% | 923,402 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 31.21B | -2.57% | 1,560,678 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.16B | -2.57% | 464,285 | 4.80B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.42B | 1.43% | 63,570 | 4.13B |
| 59 | BNTX | BioNTech SE | 28.10B | -0.61% | 715,810 | 3.03B |
| 60 | LH | Labcorp Holdings Inc. | 27.70B | 1.72% | 201,707 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.19B | 0.56% | 165,470 | 11.56B |
| 62 | ROIV | Roivant Sciences Ltd. | 26.81B | 1.01% | 1,507,842 | 7.53M |
| 63 | INSM | Insmed Incorporated | 26.76B | -1.48% | 353,071 | 1.14B |
| 64 | PHG | Koninklijke Philips N.V. | 26.35B | - | 322,081 | 20.18B |
| 65 | INCY | Incyte Corporation | 25.85B | -0.47% | 258,523 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.64B | 0.07% | 82,821 | 3.33B |
| 67 | GH | Guardant Health, Inc. | 23.04B | 0.45% | 512,566 | 1.18B |
| 68 | STE | STERIS plc | 22.87B | -0.91% | 141,767 | 6.04B |
| 69 | UTHR | United Therapeutics Corporation | 22.30B | 0.64% | 81,085 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.69B | -1.74% | 420,433 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.09B | 0.47% | 589,304 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.50B | 0.77% | 2,139,032 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.18B | -0.80% | 313,096 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.17B | -0.62% | 53,653 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.42B | -0.11% | 64,322 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.25B | 0.42% | 2,509,710 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.83B | -0.56% | 251,769 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.68B | 0.62% | 185,205 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 15.43B | -0.54% | 260,713 | 713.07M |
| 80 | CRL | Charles River Laboratories International, Inc. | 14.41B | 2.30% | 340,460 | 4.00B |
| 81 | RVTY | Revvity, Inc. | 14.37B | 1.89% | 532,888 | 2.91B |
| 82 | COO | The Cooper Companies, Inc. | 13.94B | -1.62% | 391,313 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 13.69B | -1.48% | 350,729 | 2.44B |
| 84 | BAX | Baxter International Inc. | 13.53B | -1.21% | 1,134,907 | 11.47B |
| 85 | ICLR | ICON Public Limited Company | 13.33B | 2.27% | 125,208 | 8.29B |
| 86 | TEM | Tempus AI, Inc. | 12.84B | 3.91% | 3,432,446 | 1.43B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.74B | -1.59% | 180,898 | 830.81M |
| 88 | PEN | Penumbra, Inc. | 12.70B | -0.22% | 163,329 | 1.50B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.66B | -0.95% | 1,153,895 | 14.37B |
| 90 | BMRN | BioMarin Pharmaceutical Inc. | 12.62B | -0.64% | 445,829 | 3.41B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.61B | 0.13% | 204,486 | 669.50M |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | 0.82% | 76,386 | 1.28B |
| 93 | FMS | Fresenius Medical Care AG | 12.46B | -0.26% | 349,780 | 22.19B |
| 94 | ELAN | Elanco Animal Health Incorporated | 12.30B | -1.85% | 1,161,503 | 5.02B |
| 95 | SNN | Smith & Nephew plc | 12.24B | -0.17% | 663,230 | 6.30B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 12.10B | -0.40% | 410,524 | 1.66B |
| 97 | EHC | Encompass Health Corporation | 11.77B | -1.24% | 170,261 | 6.21B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.53B | 1.55% | 2,872,422 | - |
| 99 | DVA | DaVita Inc. | 11.38B | -0.91% | 152,943 | 14.01B |
| 100 | TECH | Bio-Techne Corporation | 11.36B | 0.10% | 844,391 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.35B | 0.35% | 219,108 | 4.14B |
| 102 | GMED | Globus Medical, Inc. | 11.20B | 0.43% | 249,375 | 3.14B |
| 103 | CYTK | Cytokinetics, Incorporated | 10.95B | -0.57% | 280,027 | 67.67M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.94B | -0.15% | 196,295 | 5.67M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.75B | -0.95% | 100,448 | 776.57M |
| 106 | GKOS | Glaukos Corporation | 10.74B | 0.92% | 115,865 | 612.84M |
| 107 | KRYS | Krystal Biotech, Inc. | 10.63B | -0.18% | 47,674 | 440.48M |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.53B | 1.35% | 78,087 | 2.59B |
| 109 | IONS | Ionis Pharmaceuticals, Inc. | 10.49B | -0.41% | 333,332 | 874.09M |
| 110 | MOH | Molina Healthcare, Inc. | 10.41B | -1.31% | 119,461 | 42.47B |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.39B | -1.35% | 43,432 | 7.46M |
| 112 | UHS | Universal Health Services, Inc. | 10.31B | -2.06% | 148,093 | 18.11B |
| 113 | RDY | Dr. Reddy's Laboratories Limited | 10.26B | -0.29% | 601,383 | 3.50B |
| 114 | RGEN | Repligen Corporation | 10.25B | 0.75% | 121,609 | 785.10M |
| 115 | KYMR | Kymera Therapeutics, Inc. | 10.22B | -2.06% | 254,267 | 105.00M |
| 116 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.01% | 241,960 | - |
| 117 | ENSG | The Ensign Group, Inc. | 10.15B | -2.77% | 109,999 | 5.49B |
| 118 | HSIC | Henry Schein, Inc. | 10.12B | 0.52% | 237,321 | 13.60B |
| 119 | PODD | Insulet Corporation | 9.89B | -0.51% | 354,295 | 3.05B |
| 120 | AVTR | Avantor, Inc. | 9.85B | 0.45% | 2,212,463 | 6.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.76B | -0.46% | 144,402 | 281.99M |
| 122 | TWST | Twist Bioscience Corporation | 9.63B | 2.35% | 445,659 | 431.80M |
| 123 | OSCR | Oscar Health, Inc. | 9.51B | -1.25% | 825,601 | 15.32B |
| 124 | IBRX | ImmunityBio, Inc. | 9.19B | 5.09% | 5,716,061 | 165.79M |
| 125 | PCVX | Vaxcyte, Inc. | 9.16B | 0.73% | 155,883 | - |
| 126 | QGEN | Qiagen N.V. | 9.05B | 0.90% | 676,906 | 2.10B |
| 127 | IMVT | Immunovant, Inc. | 9.02B | -0.52% | 157,196 | - |
| 128 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.02% | 165,877 | 42.16M |
| 129 | BRKR | Bruker Corporation | 8.94B | 2.80% | 937,908 | 3.50B |
| 130 | ATR | AptarGroup, Inc. | 8.53B | -0.84% | 85,085 | 3.93B |
| 131 | TXG | 10x Genomics, Inc. | 8.36B | -0.09% | 639,739 | 616.91M |
| 132 | SYRE | Spyre Therapeutics, Inc. | 8.28B | 0.32% | 522,219 | - |
| 133 | ALKS | Alkermes plc | 8.20B | -0.62% | 221,330 | 1.67B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.79B | -0.20% | 273,587 | 799.54M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.76B | 0.80% | 86,669 | 239.92M |
| 136 | HQY | HealthEquity, Inc. | 7.76B | -11.14% | 1,295,868 | 1.36B |
| 137 | CAI | Caris Life Sciences, Inc. | 7.69B | 1.49% | 992,805 | 989.61M |
| 138 | HNGE | Hinge Health, Inc. | 7.38B | 1.12% | 796,750 | 720.06M |
| 139 | SRRK | Scholar Rock Holding Corporation | 7.22B | -1.26% | 180,272 | - |
| 140 | HIMS | Hims & Hers Health, Inc. | 7.20B | 3.42% | 4,125,266 | 2.58B |
| 141 | CHE | Chemed Corporation | 7.06B | -1.05% | 54,628 | 2.60B |
| 142 | PACS | PACS Group, Inc. | 7.05B | 0.27% | 143,211 | 5.55B |
| 143 | GRFS | Grifols, S.A. | 7.01B | -0.76% | 296,084 | 8.48B |
| 144 | CGON | CG Oncology, Inc. | 7.01B | 0.83% | 69,322 | 6.23M |
| 145 | ERAS | Erasca, Inc. | 6.95B | 3.81% | 1,508,349 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.11% | 654,359 | 1.56B |
| 147 | ORKA | Oruka Therapeutics, Inc. | 6.55B | -0.49% | 132,127 | - |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.43B | 0.46% | 113,243 | 618.07M |
| 149 | COGT | Cogent Biosciences, Inc. | 6.40B | 0.49% | 531,254 | - |
| 150 | LQDA | Liquidia Corporation | 6.38B | -0.18% | 200,256 | 450.91M |
| 151 | TVTX | Travere Therapeutics, Inc. | 6.36B | 0.58% | 270,169 | 591.33M |
| 152 | BLTE | Belite Bio, Inc | 6.30B | -0.15% | 32,286 | - |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 6.26B | -0.11% | 247,071 | 3.12B |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.25B | 0.96% | 103,244 | 1.90M |
| 155 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.25B | 1.88% | 146,474 | 840.85M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.11B | -0.78% | 170,352 | 5.32B |
| 157 | STVN | Stevanato Group S.p.A. | 6.07B | -0.63% | 69,659 | 1.40B |
| 158 | XENE | Xenon Pharmaceuticals Inc. | 6.06B | -1.96% | 160,965 | 7.50M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.97B | -1.51% | 256,381 | 1.01B |
| 160 | RDNT | RadNet, Inc. | 5.97B | -0.81% | 158,042 | 2.27B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.95B | 1.10% | 474,712 | - |
| 162 | TFX | Teleflex Incorporated | 5.86B | -0.35% | 103,466 | 2.25B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.75B | 0.46% | 399,078 | 13.39M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.69B | -0.90% | 75,755 | 290.54M |
| 165 | SHC | Sotera Health Company | 5.61B | 0.67% | 349,615 | 1.22B |
| 166 | MMED | MiniMed Group, Inc. | 5.53B | 1.03% | 350,556 | 3.10B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.35B | -1.09% | 177,879 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.12B | 0.41% | 242,367 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.92B | 0.02% | 317,907 | - |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.90B | 1.12% | 94,618 | 148.00K |
| 171 | WAY | Waystar Holding Corp. | 4.86B | 4.96% | 723,666 | 1.21B |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.81B | -0.23% | 219,637 | - |
| 173 | HAE | Haemonetics Corporation | 4.79B | -1.26% | 154,972 | 1.35B |
| 174 | LFST | LifeStance Health Group, Inc. | 4.71B | 1.48% | 561,774 | 1.58B |
| 175 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.69B | 0.70% | 554,154 | -665.00K |
| 176 | BLLN | BillionToOne, Inc. | 4.65B | 2.32% | 297,843 | 397.41M |
| 177 | CELC | Celcuity Inc. | 4.60B | -1.03% | 131,013 | - |
| 178 | DOCS | Doximity, Inc. | 4.56B | 3.48% | 677,569 | 655.57M |
| 179 | ELVN | Enliven Therapeutics, Inc. | 4.50B | 1.01% | 204,207 | - |
| 180 | NVST | Envista Holdings Corporation | 4.46B | -0.04% | 400,292 | 2.86B |
| 181 | ICUI | ICU Medical, Inc. | 4.46B | -0.72% | 87,952 | 2.16B |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.45B | 3.65% | 931,693 | 53.81M |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.42B | -0.83% | 125,036 | 2.29B |
| 184 | LIVN | LivaNova PLC | 4.40B | -0.23% | 110,521 | 1.47B |
| 185 | MANE | Veradermics, Incorporated | 4.30B | 0.02% | 119,641 | - |
| 186 | RLAY | Relay Therapeutics, Inc. | 4.29B | 0.51% | 669,498 | 10.35M |
| 187 | ADPT | Adaptive Biotechnologies Corporation | 4.28B | 2.41% | 388,254 | 308.08M |
| 188 | HTFL | HeartFlow, Inc. | 4.26B | 0.20% | 443,167 | 212.07M |
| 189 | ITGR | Integer Holdings Corporation | 4.26B | 0.13% | 135,141 | 1.84B |
| 190 | INDV | Indivior Pharmaceuticals, Inc. | 4.21B | -0.38% | 295,757 | 1.33B |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 4.01B | -0.17% | 193,196 | 234.13M |
| 192 | ABCL | AbCellera Biologics Inc. | 3.99B | 0.57% | 2,060,987 | 66.17M |
| 193 | LEGN | Legend Biotech Corporation | 3.98B | -0.73% | 357,248 | 1.27B |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.94B | -1.66% | 1,090,915 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.92B | -0.31% | 186,042 | 3.60M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.90B | -0.33% | 218,933 | 117.00M |
| 197 | IRTC | iRhythm Holdings, Inc. | 3.86B | -1.60% | 114,168 | 825.34M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.79B | 1.75% | 33,736 | 890.79M |
| 199 | GRAL | GRAIL, Inc. | 3.78B | 6.35% | 411,736 | 165.26M |
| 200 | IOVA | Iovance Biotherapeutics, Inc. | 3.72B | 1.61% | 3,624,829 | 324.97M |
| 201 | OGN | Organon & Co. | 3.61B | -0.04% | 2,014,672 | 6.13B |
| 202 | VCYT | Veracyte, Inc. | 3.61B | 1.38% | 322,098 | 561.90M |
| 203 | OPCH | Option Care Health, Inc. | 3.57B | -0.87% | 370,495 | 5.69B |
| 204 | GPCR | Structure Therapeutics Inc. | 3.53B | 0.45% | 121,937 | - |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.51B | 2.22% | 92,438 | 1.19M |
| 206 | NHC | National HealthCare Corporation | 3.50B | -0.75% | 69,757 | 1.56B |
| 207 | QURE | uniQure N.V. | 3.49B | -1.32% | 283,455 | 18.67M |
| 208 | IMNM | Immunome, Inc. | 3.28B | 0.59% | 152,640 | 4.02M |
| 209 | TMDX | TransMedics Group, Inc. | 3.25B | 1.53% | 103,622 | 668.47M |
| 210 | CLDX | Celldex Therapeutics, Inc. | 3.21B | 0.86% | 103,825 | 158.00K |
| 211 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -1.97% | 244,222 | 7.12M |
| 212 | MBX | MBX Biosciences, Inc. | 3.20B | -0.49% | 82,325 | - |
| 213 | WRBY | Warby Parker Inc. | 3.17B | 0.55% | 308,331 | 911.61M |
| 214 | IRON | Disc Medicine, Inc. | 3.16B | -0.30% | 61,073 | - |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | -0.20% | 450,168 | 463.98M |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 3.15B | 1.62% | 147,863 | 606.33M |
| 217 | ALMS | Alumis Inc. | 3.09B | 1.10% | 153,519 | 7.40M |
| 218 | BEAM | Beam Therapeutics Inc. | 3.05B | 1.26% | 305,549 | 156.04M |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 3.05B | 10.05% | 7,311,573 | - |
| 220 | ZLAB | Zai Lab Limited | 3.02B | 3.23% | 303,774 | 449.61M |
| 221 | AVAH | Aveanna Healthcare Holdings Inc. | 2.99B | 0.44% | 704,559 | 2.60B |
| 222 | BKD | Brookdale Senior Living Inc. | 2.88B | -1.27% | 937,365 | 2.93B |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.87B | -0.43% | 1,132,681 | 4.58B |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.82B | 1.87% | 270,183 | 36.77M |
| 225 | AXGN | Axogen, Inc. | 2.81B | 1.24% | 274,850 | 251.17M |
| 226 | ACHC | Acadia Healthcare Company, Inc. | 2.77B | -2.57% | 326,276 | 3.37B |
| 227 | ATAI | AtaiBeckley Inc. | 2.74B | 0.07% | 1,424,638 | 4.47M |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.73B | -0.74% | 193,688 | 71.13M |
| 229 | CDNA | CareDx, Inc. | 2.73B | 3.38% | 569,410 | 458.09M |
| 230 | RGC | Regencell Bioscience Holdings Limited | 2.72B | -0.37% | 33,232 | - |
| 231 | WGS | GeneDx Holdings Corp. | 2.69B | 0.05% | 98,595 | 454.43M |
| 232 | PRVA | Privia Health Group, Inc. | 2.67B | -0.71% | 146,279 | 2.36B |
| 233 | PGEN | Precigen, Inc. | 2.65B | -0.07% | 1,388,312 | 85.72M |
| 234 | PHVS | Pharvaris N.V. | 2.61B | 0.54% | 98,622 | - |
| 235 | SUPN | Supernus Pharmaceuticals, Inc. | 2.59B | -0.56% | 211,383 | 830.44M |
| 236 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | -1.29% | 338,093 | 717.00M |
| 237 | NEOG | Neogen Corporation | 2.56B | 0.43% | 238,539 | 870.40M |
| 238 | NKTR | Nektar Therapeutics | 2.56B | 1.61% | 141,374 | 54.59M |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.55B | 0.06% | 241,761 | - |
| 240 | KOD | Kodiak Sciences Inc. | 2.51B | 1.58% | 96,595 | - |
| 241 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.50B | -0.36% | 883,412 | 940.61M |
| 242 | NUVB | Nuvation Bio Inc. | 2.49B | 2.08% | 1,614,940 | 169.90M |
| 243 | VERA | Vera Therapeutics, Inc. | 2.48B | -6.65% | 1,421,983 | - |
| 244 | ATRC | AtriCure, Inc. | 2.47B | 0.87% | 212,555 | 569.62M |
| 245 | RAPP | Rapport Therapeutics, Inc. | 2.46B | -2.50% | 86,053 | 20.00M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.44B | -1.12% | 71,550 | 1.10B |
| 247 | NEO | NeoGenomics, Inc. | 2.44B | 9.15% | 2,473,493 | 766.30M |
| 248 | BHVN | Biohaven Ltd. | 2.41B | -5.69% | 2,684,229 | - |
| 249 | BFLY | Butterfly Network, Inc. | 2.41B | 4.63% | 1,727,898 | 112.14M |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 1.16% | 492,268 | 52.06M |
| 251 | KLRA | Kailera Therapeutics, Inc. | 2.39B | -0.11% | 175,559 | - |
| 252 | BHC | Bausch Health Companies Inc. | 2.38B | -2.23% | 970,202 | 10.85B |
| 253 | GRDN | Guardian Pharmacy Services, Inc. | 2.37B | -0.27% | 40,833 | 1.46B |
| 254 | ALMR | Alamar Biosciences, Inc. | 2.36B | -0.09% | 102,017 | 100.42M |
| 255 | UFPT | UFP Technologies, Inc. | 2.35B | -0.43% | 43,985 | 631.64M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | -0.50% | 151,591 | 959.90M |
| 257 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | -0.29% | 85,703 | - |
| 258 | COAG | Hemab Therapeutics Holdings, Inc. | 2.28B | -0.81% | 121,477 | - |
| 259 | CLOV | Clover Health Investments, Corp. | 2.27B | 0.35% | 1,411,033 | 2.48B |
| 260 | URGN | UroGen Pharma Ltd. | 2.25B | 0.30% | 226,185 | 188.73M |
| 261 | PVLA | Palvella Therapeutics, Inc. | 2.25B | 1.08% | 109,238 | - |
| 262 | MESO | Mesoblast Limited | 2.25B | 6.56% | 276,646 | 120.25M |
| 263 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.24B | -3.09% | 1,037,113 | 208.78M |
| 264 | XRAY | DENTSPLY SIRONA Inc. | 2.21B | 1.33% | 1,078,970 | 3.64B |
| 265 | TRLV | Trulieve Cannabis Corp. | 2.21B | 0.26% | 296,246 | 1.14B |
| 266 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 0.24% | 305,086 | 311.51M |
| 267 | ADUS | Addus HomeCare Corporation | 2.17B | -1.75% | 76,302 | 1.48B |
| 268 | ZBIO | Zenas BioPharma, Inc. | 2.17B | 0.67% | 226,184 | 1.00M |
| 269 | HCM | HUTCHMED (China) Limited | 2.16B | 0.69% | 35,177 | 549.12M |
| 270 | VCEL | Vericel Corporation | 2.14B | -1.51% | 140,113 | 306.30M |
| 271 | ESTA | Establishment Labs Holdings Inc. | 2.14B | -0.88% | 58,704 | 245.82M |
| 272 | MD | Pediatrix Medical Group, Inc. | 2.12B | -0.63% | 135,089 | 1.95B |
| 273 | SRPT | Sarepta Therapeutics, Inc. | 2.12B | 3.34% | 1,254,961 | 1.97B |
| 274 | GENB | Generate Biomedicines, Inc. | 2.12B | 2.42% | 1,757,351 | 26.48M |
| 275 | STOK | Stoke Therapeutics, Inc. | 2.12B | -0.66% | 133,986 | 27.59M |
| 276 | ADMA | ADMA Biologics, Inc. | 2.12B | -1.77% | 441,388 | 512.28M |
| 277 | NVCR | NovoCure Limited | 2.10B | 1.01% | 172,216 | 699.19M |
| 278 | XNCR | Xencor, Inc. | 2.10B | -0.67% | 339,840 | 104.97M |
| 279 | ZYME | Zymeworks Inc. | 2.06B | -0.73% | 145,745 | 37.13M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 1.06% | 232,936 | 98.34M |
| 281 | NBTX | Nanobiotix S.A. | 2.05B | 3.42% | 241,975 | 38.27M |
| 282 | CMPS | COMPASS Pathways plc | 2.04B | 0.92% | 628,593 | - |
| 283 | PGNY | Progyny, Inc. | 2.00B | -1.37% | 297,649 | 1.31B |
| 284 | PRGO | Perrigo Company plc | 2.00B | -2.57% | 430,665 | 4.14B |
| 285 | KARD | Kardigan, Inc. | 1.98B | -0.14% | 216,523 | - |
| 286 | GHRS | GH Research PLC | 1.97B | -0.86% | 14,509 | - |
| 287 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | 0.50% | 332,826 | 5.49M |
| 288 | ASTH | Astrana Health, Inc. | 1.96B | -1.01% | 69,485 | 3.84B |
| 289 | FBRX | Forte Biosciences, Inc. | 1.94B | - | - | - |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.91B | 1.06% | 89,502 | 1.13B |
| 291 | VIR | Vir Biotechnology, Inc. | 1.91B | 1.90% | 713,445 | 303.23M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.90B | 1.45% | 46,994 | - |
| 293 | IMCR | Immunocore Holdings plc | 1.90B | -0.59% | 45,499 | 430.78M |
| 294 | SEPN | Septerna, Inc. | 1.89B | 0.67% | 48,624 | 98.88M |
| 295 | INBX | Inhibrx Biosciences, Inc. | 1.87B | 1.24% | 83,420 | 1.30M |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | -0.43% | 4,977,099 | 54.86M |
| 297 | PSNL | Personalis, Inc. | 1.85B | 1.52% | 872,361 | 69.67M |
| 298 | NTLA | Intellia Therapeutics, Inc. | 1.85B | -0.08% | 803,209 | 59.51M |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.84B | -2.24% | 106,279 | 481.07M |
| 300 | BRVE | Braveheart Bio, Inc. | 1.83B | 2.92% | 28,549 | - |
| 301 | BLFS | BioLife Solutions, Inc. | 1.82B | 0.51% | 330,302 | 106.69M |
| 302 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -0.35% | 58,476 | 262.43M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.81B | 2.75% | 350,354 | 2.68B |
| 304 | SGRY | Surgery Partners, Inc. | 1.80B | -1.07% | 371,954 | 3.37B |
| 305 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | -0.10% | 147,298 | 252.25M |
| 306 | ETON | Eton Pharmaceuticals, Inc. | 1.79B | -0.16% | 94,846 | 105.60M |
| 307 | INSP | Inspire Medical Systems, Inc. | 1.78B | -0.24% | 75,740 | 898.74M |
| 308 | ALVO | Alvotech | 1.74B | -0.71% | 517,741 | 494.61M |
| 309 | AAPG | Ascentage Pharma Group International | 1.73B | 9.41% | 13,857 | 94.61M |
| 310 | ANAB | AnaptysBio, Inc. | 1.71B | -0.62% | 313,260 | 232.39M |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.65B | 1.13% | 156,920 | - |
| 312 | ABSI | Absci Corporation | 1.65B | 4.01% | 1,744,798 | 1.56M |
| 313 | APMD | Apnimed, Inc. | 1.64B | 0.07% | 198,817 | 120.15M |
| 314 | LTGO | Latigo Biotherapeutics, Inc. | 1.63B | 6.51% | 63,325 | - |
| 315 | AVLN | Avalyn Pharma Inc. | 1.62B | -1.32% | 58,271 | - |
| 316 | TRAX | First Tracks Biotherapeutics, Inc. | 1.59B | 0.66% | 108,785 | - |
| 317 | AGL | agilon health, inc. | 1.59B | -1.18% | 61,192 | 5.92B |
| 318 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -0.68% | 55,704 | 978.38M |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.59B | 1.37% | 46,354 | - |
| 320 | XERS | Xeris Biopharma Holdings, Inc. | 1.58B | - | 328,107 | 335.41M |
| 321 | MAZE | Maze Therapeutics, Inc. | 1.58B | -3.82% | 333,208 | 20.00M |
| 322 | ARDT | Ardent Health, Inc. | 1.58B | -0.53% | 82,776 | 6.41B |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.56B | -0.57% | 86,280 | 1.86B |
| 324 | KMTS | Kestra Medical Technologies, Ltd. | 1.56B | 0.19% | 56,433 | 95.13M |
| 325 | LBRX | LB Pharmaceuticals Inc | 1.54B | -0.90% | 63,645 | - |
| 326 | OMCL | Omnicell, Inc. | 1.53B | 0.54% | 116,050 | 1.25B |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.67% | 121,947 | - |
| 328 | TNDM | Tandem Diabetes Care, Inc. | 1.52B | 2.15% | 314,132 | 1.04B |
| 329 | INVA | Innoviva, Inc. | 1.52B | -1.08% | 126,453 | 440.00M |
| 330 | CNMD | CONMED Corporation | 1.52B | 0.38% | 47,990 | 1.37B |
| 331 | REPL | Replimune Group, Inc. | 1.51B | 1.16% | 718,783 | - |
| 332 | INNV | InnovAge Holding Corp. | 1.51B | 0.54% | 24,500 | 949.17M |
| 333 | AKTS | Aktis Oncology, Inc. | 1.50B | 1.96% | 79,572 | 10.06M |
| 334 | OMDA | Omada Health, Inc. | 1.50B | 2.09% | 367,333 | 309.76M |
| 335 | FRNM | Freenome, Inc. | 1.49B | -1.35% | 109,503 | 35.41M |
| 336 | SDGR | Schrödinger, Inc. | 1.49B | 2.47% | 214,200 | 259.04M |
| 337 | SLBT | SL Science Holding Limited | 1.49B | 0.38% | 29,014 | 3.27M |
| 338 | NVAX | Novavax, Inc. | 1.49B | -2.06% | 1,285,935 | 413.80M |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.48B | 1.75% | 524,859 | 815.05M |
| 340 | CGEM | Cullinan Therapeutics, Inc. | 1.46B | -0.39% | 169,460 | - |
| 341 | PAHC | Phibro Animal Health Corporation | 1.46B | -0.06% | 123,878 | 1.52B |
| 342 | ORIC | ORIC Pharmaceuticals, Inc. | 1.46B | 1.47% | 287,095 | - |
| 343 | AZTA | Azenta, Inc. | 1.46B | -0.63% | 151,616 | 613.81M |
| 344 | ENOV | Enovis Corporation | 1.46B | 0.04% | 76,701 | 2.30B |
| 345 | HROW | Harrow, Inc. | 1.46B | -1.30% | 203,478 | 275.59M |
| 346 | ANRO | Alto Neuroscience, Inc. | 1.43B | -0.14% | 106,294 | - |
| 347 | SPTX | Seaport Therapeutics, Inc. | 1.43B | -4.09% | 61,136 | - |
| 348 | SVRA | Savara Inc. | 1.43B | 0.09% | 339,349 | - |
| 349 | VOR | Vor Biopharma Inc. | 1.40B | -0.30% | 164,342 | - |
| 350 | JBIO | Jade Biosciences, Inc. | 1.39B | 2.32% | 91,852 | - |
| 351 | OMER | Omeros Corporation | 1.38B | 4.94% | 673,617 | 38.42M |
| 352 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 0.07% | 166,619 | - |
| 353 | MGTX | MeiraGTx Holdings plc | 1.38B | -1.24% | 304,718 | 397.50M |
| 354 | AMN | AMN Healthcare Services, Inc. | 1.35B | 1.43% | 69,922 | 3.43B |
| 355 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.38% | 484,087 | - |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.32B | 0.77% | 79,136 | 1.65B |
| 357 | PNTG | The Pennant Group, Inc. | 1.32B | -1.11% | 55,039 | 1.10B |
| 358 | NUTX | Nutex Health Inc. | 1.32B | -1.53% | 46,042 | 846.72M |
| 359 | MNKD | MannKind Corporation | 1.31B | -0.12% | 826,570 | 393.63M |
| 360 | CRON | Cronos Group Inc. | 1.31B | -0.14% | 888,125 | 179.09M |
| 361 | AORT | Artivion, Inc. | 1.30B | -1.65% | 77,349 | 471.47M |
| 362 | CERT | Certara, Inc. | 1.29B | 2.92% | 348,132 | 421.75M |
| 363 | IMTX | Immatics N.V. | 1.27B | -1.27% | 128,059 | 47.65M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 1.56% | 115,976 | - |
| 365 | SANA | Sana Biotechnology, Inc. | 1.25B | 0.24% | 693,583 | - |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 1.24B | 1.04% | 423,187 | 28.73M |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 1.23B | 0.39% | 65,496 | 99.00K |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.20B | -3.29% | 491,798 | 785.23M |
| 369 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | -1.47% | 214,278 | 337.34M |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 0.56% | 46,808 | 804.27M |
| 371 | KURA | Kura Oncology, Inc. | 1.17B | 1.07% | 753,559 | 77.23M |
| 372 | BVS | Bioventus Inc. | 1.17B | -0.29% | 115,164 | 581.85M |
| 373 | JANX | Janux Therapeutics, Inc. | 1.16B | 0.26% | 144,842 | 24.00M |
| 374 | TDOC | Teladoc Health, Inc. | 1.15B | 0.16% | 902,375 | 2.49B |
| 375 | IVA | Inventiva S.A. | 1.14B | 2.80% | 452,230 | 7.94M |
| 376 | OPK | OPKO Health, Inc. | 1.13B | 0.33% | 1,552,728 | 587.90M |
| 377 | STAA | STAAR Surgical Company | 1.13B | -1.40% | 102,360 | 339.59M |
| 378 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | -1.92% | 66,972 | 1.04B |
| 379 | IRMD | IRADIMED CORPORATION | 1.12B | -0.23% | 29,878 | 86.34M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.08B | -1.56% | 88,263 | 59.00K |
| 381 | SLDB | Solid Biosciences Inc. | 1.08B | 3.60% | 343,300 | - |
| 382 | CADL | Candel Therapeutics, Inc. | 1.07B | 4.97% | 539,399 | - |
| 383 | CSTL | Castle Biosciences, Inc. | 1.06B | 1.58% | 57,080 | 357.28M |
| 384 | QDEL | QuidelOrtho Corporation | 1.05B | 2.28% | 267,973 | 2.67B |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.65% | 656,780 | 41.47M |
| 386 | WVE | Wave Life Sciences, Inc. | 1.03B | 0.38% | 1,290,715 | 65.37M |
| 387 | PCRX | Pacira BioSciences, Inc. | 1.03B | -0.06% | 124,437 | 746.16M |
| 388 | IMMX | Immix Biopharma, Inc. | 1.03B | 2.27% | 531,427 | - |
| 389 | ABUS | Arbutus Biopharma Corporation | 1.02B | -0.29% | 1,197,932 | 181.72M |
| 390 | GMRS | GMR Solutions Inc. | 997.95M | 0.16% | 90,863 | 5.88B |
| 391 | GERN | Geron Corporation | 982.98M | - | 2,545,567 | 204.56M |
| 392 | HELP | Cybin Inc. | 979.01M | -1.69% | 443,147 | - |
| 393 | DSGN | Design Therapeutics, Inc. | 966.26M | -0.96% | 133,127 | - |
| 394 | ANNX | Annexon, Inc. | 964.01M | 1.90% | 1,102,702 | - |
| 395 | ARDX | Ardelyx, Inc. | 954.39M | - | 905,308 | 450.89M |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 948.47M | -0.09% | 115,210 | - |
| 397 | ANL | Adlai Nortye Ltd. | 941.50M | -2.92% | 71,589 | 18.06M |
| 398 | GLAS | Glass House Brands Inc. | 935.83M | -4.52% | 116,249 | 176.98M |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 931.58M | -0.54% | 64,163 | 730.02M |
| 400 | ACRS | Aclaris Therapeutics, Inc. | 913.37M | 0.24% | 388,695 | 8.22M |
| 401 | SGP | SpyGlass Pharma, Inc. | 909.79M | 2.10% | 14,053 | - |
| 402 | CBLL | CeriBell, Inc. | 907.26M | 0.81% | 43,858 | 101.96M |
| 403 | CLYM | Climb Bio, Inc. | 897.15M | -2.86% | 448,142 | - |
| 404 | ATTO | Attovia Therapeutics, Inc. | 894.14M | 6.29% | 48,335 | 1.35M |
| 405 | AVR | Anteris Technologies Global Corp. | 888.33M | 1.84% | 100,660 | 2.24M |
| 406 | TBPH | Theravance Biopharma, Inc. | 886.25M | 0.23% | 126,969 | 104.31M |
| 407 | BBNX | Beta Bionics, Inc. | 877.30M | 0.83% | 88,082 | 119.01M |
| 408 | SIBN | SI-BONE, Inc. | 875.31M | 0.51% | 311,127 | 213.60M |
| 409 | COLL | Collegium Pharmaceutical, Inc. | 873.30M | -2.49% | 210,827 | 808.21M |
| 410 | RIGL | Rigel Pharmaceuticals, Inc. | 869.92M | 0.19% | 52,749 | 276.79M |
| 411 | ACHV | Achieve Life Sciences, Inc. | 859.24M | 0.97% | 465,163 | - |
| 412 | INMD | InMode Ltd. | 856.18M | -0.23% | 112,269 | 374.63M |
| 413 | FTH | Faeth Therapeutics, Inc. | 852.48M | 0.06% | 77,220 | - |
| 414 | HSTM | HealthStream, Inc. | 849.13M | 0.97% | 39,697 | 321.12M |
| 415 | DBVT | DBV Technologies S.A. | 848.13M | -1.21% | 101,761 | 5.04M |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 844.68M | -1.74% | 200,499 | 92.01M |
| 417 | AHG | Akso Health Group | 831.26M | -1.99% | 5,506 | 13.83M |
| 418 | PHAR | Pharming Group N.V. | 829.58M | -0.38% | 3,059 | 366.48M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 824.64M | 1.24% | 100,693 | - |
| 420 | SLN | Silence Therapeutics plc | 820.05M | 0.67% | 144,343 | 615.00K |
| 421 | AURA | Aura Biosciences, Inc. | 804.75M | 0.39% | 108,116 | - |
| 422 | STTK | Shattuck Labs, Inc. | 787.35M | -0.70% | 181,594 | 1.00M |
| 423 | OCS | Oculis Holding AG | 780.29M | -2.54% | 32,275 | 1.45M |
| 424 | VREX | Varex Imaging Corporation | 779.53M | 0.08% | 179,856 | 865.00M |
| 425 | MNPR | Monopar Therapeutics Inc. | 778.18M | 1.95% | 60,115 | - |
| 426 | OBX | Obsidian Therapeutics, Inc. | 775.97M | -2.66% | 20,591 | - |
| 427 | NGNE | Neurogene Inc. | 771.14M | 0.33% | 43,764 | 925.00K |
| 428 | CBIO | Crescent Biopharma, Inc. | 763.14M | -1.05% | 20,708 | 11.88M |
| 429 | DRUG | Bright Minds Biosciences Inc. | 760.37M | -0.68% | 23,496 | - |
| 430 | AHCO | AdaptHealth Corp. | 745.76M | -1.41% | 554,083 | 3.36B |
| 431 | SOPH | SOPHiA GENETICS SA | 742.31M | 2.23% | 203,704 | 86.17M |
| 432 | PHR | Phreesia, Inc. | 735.56M | 2.59% | 156,305 | 495.59M |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 734.40M | -1.08% | 49,855 | - |
| 434 | ALLO | Allogene Therapeutics, Inc. | 732.44M | 3.92% | 2,188,832 | 4.64M |
| 435 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 1.20% | 937,914 | 18.30M |
| 436 | MPLT | MapLight Therapeutics, Inc. | 731.93M | 2.41% | 116,120 | - |
| 437 | TECX | Tectonic Therapeutic, Inc. | 731.15M | 3.98% | 157,874 | - |
| 438 | ASMB | Assembly Biosciences, Inc. | 719.34M | -0.25% | 54,549 | 74.85M |
| 439 | GYRE | Gyre Therapeutics, Inc. | 710.43M | 0.75% | 9,161 | 109.82M |
| 440 | IRWD | Ironwood Pharmaceuticals, Inc. | 707.06M | -0.26% | 334,488 | 389.32M |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 701.62M | 0.64% | 206,681 | 136.07M |
| 442 | SSII | SS Innovations International, Inc. | 701.37M | -1.96% | 32,130 | 52.40M |
| 443 | AGMB | AgomAb Therapeutics NV | 701.29M | -0.28% | 118,671 | - |
| 444 | EVO | Evotec SE | 694.60M | 0.05% | 15,942 | 819.47M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 688.66M | -1.14% | 279,781 | 239.66M |
| 446 | VSTM | Verastem, Inc. | 673.79M | 0.68% | 490,664 | 87.53M |
| 447 | MDXG | MiMedx Group, Inc. | 670.50M | 4.07% | 670,853 | 355.17M |
| 448 | PRLD | Prelude Therapeutics Incorporated | 666.89M | -1.30% | 212,243 | 22.42M |
| 449 | SGMT | Sagimet Biosciences Inc. | 666.34M | -1.29% | 236,983 | - |
| 450 | OABI | OmniAb, Inc. | 664.43M | -4.99% | 479,962 | 38.46M |
| 451 | CTEV | Claritev Corporation | 662.31M | 4.02% | 40,991 | 994.67M |
| 452 | STLN | Starling Oncology, Inc. | 657.36M | -1.68% | 1,123,501 | 587.24M |
| 453 | ANGO | AngioDynamics, Inc. | 655.95M | 1.15% | 77,667 | 320.17M |
| 454 | CRMD | CorMedix Inc. | 653.17M | -0.12% | 266,368 | 462.25M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 651.41M | -3.71% | 2,097,202 | 54.09M |
| 456 | PRME | Prime Medicine, Inc. | 645.79M | 1.40% | 961,391 | 4.07M |
| 457 | AUTL | Autolus Therapeutics plc | 632.14M | 1.93% | 607,434 | 117.39M |
| 458 | EIKN | Eikon Therapeutics, Inc. | 631.56M | -2.67% | 114,555 | - |
| 459 | CTNM | Contineum Therapeutics, Inc. | 628.27M | -1.88% | 53,451 | - |
| 460 | VALN | Valneva SE | 627.52M | -1.57% | 10,641 | 163.30M |
| 461 | TLRY | Tilray Brands, Inc. | 623.15M | -0.97% | 1,331,764 | 915.45M |
| 462 | ALT | Altimmune, Inc. | 622.46M | 1.59% | 953,943 | 31.00K |
| 463 | KIDS | OrthoPediatrics Corp. | 614.75M | -2.02% | 68,505 | 252.72M |
| 464 | ARVN | Arvinas, Inc. | 614.63M | 0.86% | 184,178 | 316.70M |
| 465 | RGNX | REGENXBIO Inc. | 611.28M | -1.28% | 303,537 | 174.48M |
| 466 | CTKB | Cytek Biosciences, Inc. | 602.47M | 1.42% | 135,802 | 206.71M |
| 467 | SPRY | ARS Pharmaceuticals, Inc. | 601.66M | 0.33% | 356,214 | 116.93M |
| 468 | CAPR | Capricor Therapeutics, Inc. | 601.16M | 10.47% | 6,564,052 | 11.13M |
| 469 | BLSM | BlossomHill Therapeutics, Inc. | 592.04M | 4.66% | 42,184 | - |
| 470 | EOLS | Evolus, Inc. | 591.15M | 1.94% | 421,256 | 316.49M |
| 471 | ARTV | Artiva Biotherapeutics, Inc. | 584.73M | 1.61% | 105,975 | 251.00K |
| 472 | WEAV | Weave Communications, Inc. | 583.59M | -0.21% | 2,075,093 | 257.79M |
| 473 | BWAY | BrainsWay Ltd. | 573.33M | 1.26% | 48,325 | 60.70M |
| 474 | DCTH | Delcath Systems, Inc. | 566.63M | -0.43% | 106,179 | 95.42M |
| 475 | ZURA | Zura Bio Limited | 566.35M | -1.34% | 512,536 | - |
| 476 | CABA | Cabaletta Bio, Inc. | 558.65M | 1.38% | 1,425,991 | - |
| 477 | OVID | Ovid Therapeutics Inc. | 558.55M | -0.69% | 333,347 | 1.58M |
| 478 | SRTA | Strata Critical Medical, Inc. | 554.69M | 2.45% | 362,568 | 255.98M |
| 479 | CERS | Cerus Corporation | 552.18M | - | 329,048 | 221.55M |
| 480 | FLGT | Fulgent Genetics, Inc. | 550.31M | 0.96% | 87,852 | 323.93M |
| 481 | ENTX | Entera Bio Ltd. | 547.13M | -0.94% | 102,415 | 42.00K |
| 482 | PROK | ProKidney Corp. | 541.16M | 2.87% | 296,976 | 818.00K |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 537.42M | 0.93% | 145,363 | - |
| 484 | TCMD | Tactile Systems Technology, Inc. | 534.82M | 0.43% | 62,446 | 350.31M |
| 485 | EVH | Evolent Health, Inc. | 530.81M | -4.57% | 832,767 | 2.10B |
| 486 | SCTX | Scribe Therapeutics Inc. | 525.18M | -12.18% | 97,736 | 36.28M |
| 487 | CCCC | C4 Therapeutics, Inc. | 523.47M | 0.35% | 847,180 | 35.04M |
| 488 | RZLT | Rezolute, Inc. | 521.81M | -0.89% | 219,344 | - |
| 489 | EVMN | Evommune, Inc. | 505.55M | -1.28% | 111,749 | 10.00M |
| 490 | SENS | Senseonics Holdings, Inc. | 505.48M | 2.36% | 119,514 | 48.55M |
| 491 | NPCE | NeuroPace, Inc. | 504.57M | 0.14% | 31,581 | 106.99M |
| 492 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 493 | CLPT | ClearPoint Neuro, Inc. | 503.62M | 0.86% | 194,379 | 42.28M |
| 494 | EDIT | Editas Medicine, Inc. | 502.97M | 2.99% | 1,152,914 | 47.01M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 494.95M | 1.66% | 273,962 | 132.42M |
| 496 | NRC | NRC Health | 491.94M | 1.09% | 24,843 | 140.00M |
| 497 | PACB | Pacific Biosciences of California, Inc. | 491.11M | 1.28% | 3,549,319 | 159.27M |
| 498 | KMDA | Kamada Ltd. | 490.45M | -2.27% | 80,449 | 191.85M |
| 499 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.92M | -0.27% | 75,871 | - |
| 500 | RLMD | Relmada Therapeutics, Inc. | 485.88M | 0.11% | 125,298 | - |